Case Studies & Whitepapers2024-09-18
From R&D to Phase III: Peptide 39AA Project Completed in 10 Months
News
More
Case Studies & Whitepapers2025-06-27
Multiple Approaches to Address the Challenges of Oral Absorption of PROTAC Drugs
As a global CDMO serving global innovative pharmaceutical companies and research institutions, Porton has an extensive experience in research and manufacturing services, especially in the field of PROTAC drug development. Porton is committed to the development and production of PROTAC oral formulations and provides customers with comprehensive, reliable, fast, and compliant one-stop services, to meet customers' supply chain needs and facilitating the commercial success of their products from research and development to order fulfillment.
Case Studies & Whitepapers2025-06-04
Flow Chemistry: A New Technology to Enhance the Traditional Batch Process in the Delivery Requirement
Continuous reaction can effectively solve the problem of "amplification effect" in batch processes from research and development to pilot testing, and then again to commercial production. Porton’s continuous reaction capabilities include low-temperature lithiation reaction, ozone oxidation reaction, nitrification reaction, high-temperature reaction, and organic azide reaction, etc., which can achieve process development and technology transfer from research and development to production application.
